Vittoria Vardanega

Health and data journalist. I cover a wide range of healthcare topics, from cutting-edge therapies to global health. My stories are often data-driven, and I strive to make complex issues clear and accessible. Before becoming a full-time journalist, I worked in communication, research, and data analysis for the UN and EU. In the private sector, I developed health economics models to inform policy and investment decisions. Originally from Italy, I am now based in Zurich.

Microscope screen of a colon cancer cell.

New treatments

More young adults are getting bowel cancer. Is Switzerland screening too late?

This content was published on Dec 10, 2025 Colorectal cancer rates are growing among the under-50. When is the right time to scan?

Female patient lying in hospital bed (KEYSTONE/PHOTOALTO "S/Michele Constantini)

Medicine access

Under-50s cancer patients face system unprepared for them

This content was published on Nov 17, 2025 Countries, including Switzerland, are struggling to deal with the challenges posed by rising cancer rates among people under 50.

Medicine access

Dealing with vaccine hesitancy in the age of misinformation – lessons from Switzerland

This content was published on Jul 12, 2025 In Switzerland, complementary and alternative medicine is key to addressing vaccine hesitancy.

A pharmacist with a customer in France offering a generic drug.

Pharma supply chains

How US tariffs could disrupt the generic drugs supply chain

This content was published on Jul 1, 2025 US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.

Patient safety

Global concern over measles is rising. Should Switzerland worry?

This content was published on May 30, 2025 Measles is making a global comeback. In Switzerland, a crisis is unlikely – but authorities warn a strong vaccination rate remains crucial.

MMR vaccine. Syringe and vial on a counter. This combined vaccine protects infants from three viral diseases: measles, mumps and rubella.

Medicine access

One paper, 20 years of damage

This content was published on May 30, 2025 Nearly 30 years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.

Vittoria Vardanega

More

More young adults are getting bowel cancer. Is Switzerland screening too late?

More

Under-50s cancer patients face system unprepared for them

More

Dealing with vaccine hesitancy in the age of misinformation – lessons from Switzerland

More

How US tariffs could disrupt the generic drugs supply chain

More

Global concern over measles is rising. Should Switzerland worry?

More

One paper, 20 years of damage

Popular Stories

Most Discussed